Bristol Myers Squibb invests over $400m in sterile drug product facility 22-Feb-2024 By Isabel Cameron Bristol Myers Squibb is investing over $400 million to build a sterile drug product facility at its Dublin campus.
Aldevron expands mRNA production capability 09-May-2023 By Isabel Cameron Aldevron is expanding its mRNA production capabilities to include lipid nanoparticle (LNP) encapsulation and aseptic fill-finish capabilities.
WuXi Biologics launches drug product facility in China for pre-filled syringes 08-Jun-2022 By Jane Byrne WuXi Biologics says it has successfully launched the GMP operation of its new drug product facility, DP5, which is located in Wuxi, China.
